• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较 50%细胞培养感染剂量测定法和噬斑测定法得出的腮腺炎病毒效价估计值。

Comparisons of mumps virus potency estimates obtained by 50% cell culture infective dose assay and plaque assay.

机构信息

Molecular Biomedicine Unit, Research and Development Department, Institute of Immunology Inc, Rockefellerova 10, 10000 Zagreb, Croatia.

出版信息

Vaccine. 2010 Feb 17;28(7):1887-92. doi: 10.1016/j.vaccine.2009.11.049. Epub 2009 Dec 2.

DOI:10.1016/j.vaccine.2009.11.049
PMID:19961964
Abstract

The two most commonly used methods for the determination of a virus potency are plaque assay and 50% cell culture infective dose (CCID(50)) assay, both based on cytopathic effect observation. We compared the potency estimates obtained by plaque and CCID(50) assays for nine mumps virus strains that produce different cytopathic effects in Vero cells. The ratios of CCID(50) and plaque assay quantification results differed for different strains and were in a range of 0.66-10, indicating that quantification results for some mumps virus strains are almost identical regardless of whether CCID(50) or plaque method is used, while the potency estimates of other strains strongly depend on the choice of the assay.

摘要

两种最常用于测定病毒效价的方法是噬斑测定法和 50%细胞培养感染剂量(CCID(50))测定法,这两种方法均基于细胞病变效应观察。我们比较了在 Vero 细胞中产生不同细胞病变效应的九株腮腺炎病毒株的噬斑测定法和 CCID(50)测定法得到的效价估计值。不同毒株的 CCID(50)和噬斑测定法定量结果比值在 0.66-10 之间,这表明,无论使用 CCID(50)法还是噬斑法,一些腮腺炎病毒株的定量结果几乎完全相同,而其他毒株的效价估计值则强烈依赖于测定方法的选择。

相似文献

1
Comparisons of mumps virus potency estimates obtained by 50% cell culture infective dose assay and plaque assay.比较 50%细胞培养感染剂量测定法和噬斑测定法得出的腮腺炎病毒效价估计值。
Vaccine. 2010 Feb 17;28(7):1887-92. doi: 10.1016/j.vaccine.2009.11.049. Epub 2009 Dec 2.
2
Potency estimation of measles, mumps and rubella trivalent vaccines with quantitative PCR infectivity assay.采用定量PCR感染性测定法对麻疹、腮腺炎和风疹三联疫苗进行效价评估。
Biologicals. 2005 Jun;33(2):71-9. doi: 10.1016/j.biologicals.2005.01.001. Epub 2005 Apr 7.
3
Study of the behaviour of the mumps virus in different cell culture systems.腮腺炎病毒在不同细胞培养系统中的行为研究。
Roum Arch Microbiol Immunol. 1992 Jul-Sep;51(3):131-5.
4
In vitro potency assay for yellow fever vaccines: comparison of three vero cell lines sources.黄热病疫苗的体外效力测定:三种非洲绿猴肾细胞系来源的比较
Biologicals. 2000 Mar;28(1):33-40. doi: 10.1006/biol.1999.0239.
5
Assessment of mumps virus growth on various continuous cell lines by virological, immunological, molecular and morphological investigations.通过病毒学、免疫学、分子学和形态学研究评估腮腺炎病毒在各种连续细胞系上的生长情况。
J Virol Methods. 2005 Jun;126(1-2):149-56. doi: 10.1016/j.jviromet.2005.01.032.
6
Reproduction of mumps virus strains in Vero cell cultures at 32, 37 and 40 degrees C.腮腺炎病毒毒株在32、37和40摄氏度的Vero细胞培养物中的繁殖情况。
Acta Virol. 1981 Jul;25(4):213-8.
7
Development of a focus reduction neutralization test (FRNT) for detection of mumps virus neutralizing antibodies.建立一种用于检测腮腺炎病毒中和抗体的焦点减少中和试验(FRNT)。
J Virol Methods. 2010 Jan;163(1):153-6. doi: 10.1016/j.jviromet.2009.09.006. Epub 2009 Sep 15.
8
The mumps virus neurovirulence safety test in Rhesus monkeys: a comparison of mumps virus strains.恒河猴中腮腺炎病毒神经毒力安全性测试:腮腺炎病毒株比较
J Infect Dis. 1999 Aug;180(2):521-5. doi: 10.1086/314905.
9
[Genetic markers of the mumps virus].[腮腺炎病毒的基因标记]
Lijec Vjesn. 1990 Jan-Feb;112(1-2):13-6.
10
Estimation of the number of infectious measles viruses in live virus vaccines using quantitative real-time PCR.使用定量实时聚合酶链反应估计活病毒疫苗中感染性麻疹病毒的数量。
J Virol Methods. 2004 May;117(2):179-87. doi: 10.1016/j.jviromet.2004.01.009.

引用本文的文献

1
and effects of root extract EPs 7630 and selected constituents against SARS-CoV-2 B.1, Delta AY.4/AY.117 and Omicron BA.2.以及根提取物EPs 7630和选定成分对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)B.1、德尔塔AY.4/AY.117和奥密克戎BA.2的作用。
Front Pharmacol. 2023 Jul 26;14:1214351. doi: 10.3389/fphar.2023.1214351. eCollection 2023.
2
Population Variability Generated during Rescue Process and Passaging of Recombinant Mumps Viruses.在重组腮腺炎病毒的拯救过程和传代过程中产生的人群变异性。
Viruses. 2021 Dec 20;13(12):2550. doi: 10.3390/v13122550.
3
Influence of Ribavirin on Mumps Virus Population Diversity.
利巴韦林对腮腺炎病毒种群多样性的影响。
Viruses. 2021 Dec 17;13(12):2535. doi: 10.3390/v13122535.
4
Production- and Purification-Relevant Properties of Human and Murine Cytomegalovirus.人巨细胞病毒和鼠巨细胞病毒的生产和纯化相关特性。
Viruses. 2021 Dec 10;13(12):2481. doi: 10.3390/v13122481.
5
Antiviral and Immunomodulatory Effects of Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells.根提取物EPs® 7630对感染SARS-CoV-2的人肺细胞的抗病毒和免疫调节作用
Front Pharmacol. 2021 Oct 25;12:757666. doi: 10.3389/fphar.2021.757666. eCollection 2021.
6
Multiplex PCR-based titration (MPBT) assay for determination of infectious titers of the three Sabin strains of live poliovirus vaccine.基于多重聚合酶链反应的滴定(MPBT)检测法,用于测定三株脊髓灰质炎活疫苗病毒株的感染滴度。
Virol J. 2019 Oct 28;16(1):122. doi: 10.1186/s12985-019-1233-6.
7
Mass spectrometry-based investigation of measles and mumps virus proteome.基于质谱的麻疹和腮腺炎病毒蛋白质组学研究。
Virol J. 2018 Oct 16;15(1):160. doi: 10.1186/s12985-018-1073-9.
8
Easy and Rapid Detection of Mumps Virus by Live Fluorescent Visualization of Virus-Infected Cells.通过病毒感染细胞的实时荧光可视化轻松快速检测腮腺炎病毒
PLoS One. 2015 Dec 2;10(12):e0144038. doi: 10.1371/journal.pone.0144038. eCollection 2015.
9
Factors influencing preclinical in vivo evaluation of mumps vaccine strain immunogenicity.影响腮腺炎疫苗株免疫原性临床前体内评估的因素。
Hum Vaccin Immunother. 2015;11(10):2446-54. doi: 10.1080/21645515.2015.1062191.
10
Stability of Minimum Essential Medium functionality despite L-glutamine decomposition.尽管L-谷氨酰胺分解,但最低基本培养基功能仍保持稳定。
Cytotechnology. 2016 Aug;68(4):1171-83. doi: 10.1007/s10616-015-9875-8. Epub 2015 Apr 24.